Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Why Traditional Agencies Are Failing Pharma CMOs in 2025
In 2025, pharma CMOs in India are staring down a familiar problem with a growing sense of impatience. They’re pouring money into campaigns, building brand assets, running awareness programs, but…
|
How to Build a Marketing Ecosystem, Not Just Run Campaigns
Most pharma companies in India are still chasing campaigns. Monthly plans, burst tactics, launch calendars: then rinse and repeat. But let’s be honest. Campaigns aren’t enough anymore. Not in 2025.…
|
Pharma Compliance Marketing for a Regulated Digital Era
Pharma compliance marketing helps brands manage Schedule H rules, ensure ethical HCP engagement, maintain audit trails, and drive trust through compliant systems.
|
Pharma Marketing Velocity Turning Digital Maturity Into Impact
Pharma marketing velocity connects tools, teams, and compliance systems to drive faster digital execution, improve doctor engagement, and boost marketing ROI.
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
